Further corroborating that blood neurofilaments increase in at-risk individuals nearing phenoconversion are studies of presymptomatic individuals with mutations in C9orf72 (associated with ALS and FTD), or in GRN or MAPT (associated with FTD). Here, C9orf72 is linked to amyotrophic lateral sclerosis.